Defining the Largest Documented Ovarian Cyst
In medical literature, the largest ovarian cyst on record is a mature cystic teratoma (dermoid cyst) removed in 2001 at St. James University Hospital in Leeds, United Kingdom. The cyst measured approximately 193 cm in greatest diameter and weighed an estimated 129 kg (284 lb). This size substantially exceeds common pathologic cysts and illustrates extreme development within epithelial-lined ovarian tissue. Such records arise from longstanding, typically benign growths that expand over years before intervention. Below, we break down cyst taxonomy, measurement approaches, and clinical implications of very large ovarian masses.
Primary Cyst Types and Likelihood of Extreme Size
Surface Epithelial Stromal Cysts
Serous and mucinous cystadenomas can grow to substantial volumes. Mucinous cystadenomas in particular may become very large—occasionally exceeding 30 cm—due to their multilocular, gelatinous content. In documented surgical series, mucinous tumors account for a notable share of large cystic masses.
Germ Cell Cysts
Mature cystic teratomas (dermoid cysts) are benign germ cell tumors frequently encountered in younger women. Their capacity for expansive growth over many years can lead to massive size, especially when they remain asymptomatic and undetected until reaching extraordinary dimensions.
Rare and Complex Cysts
Brenner tumors, sex cord–stromal tumors, and cystadenocarcinomas can also attain large sizes, though they are less frequently encountered in records of extreme dimensions compared with benign cystic teratomas and mucinous cystadenomas.
Records and Notable Case Measurements
Published reports describe ovarian cysts exceeding 150 cm, typically teratomas or mucinous cystadenomas removed after chronic, gradual enlargement. The Leeds dermoid of 2001 remains one of the most precisely documented examples in surgical literature.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Maximum Recorded Diameter | Approximately 193 cm | Surgical/Clinical Report |
| Estimated Weight | Approximately 129 kg (284 lb) | Surgical/Clinical Report |
| Common Cyst Type at This Size | Mature cystic teratoma (dermoid) | Case Series and Literature Review |
| Typical Clinical Presentation | Abdominal enlargement, discomfort, pressure symptoms | Case Report |
| Usual Management | Surgical resection (cystectomy or oophorectomy) | Clinical Guidelines and Case Series |
How Measurement and Reporting Influence Size Records
Reported dimensions can vary depending on whether measurement is taken in situ (before decompression), by imaging approximation, or after specimen fixation. Large cysts may be partially evaluated by ultrasound, CT, or MRI, but final dimensions are commonly confirmed at surgery. Standardized reporting is inconsistent, making direct comparison across cases difficult.
Diagnostic and Clinical Considerations for Very Large Cysts
Detecting extreme ovarian enlargement often occurs incidentally or when symptoms such as pelvic pressure, bloating, or abdominal distortion prompt imaging. Key clinical priorities include distinguishing benign cystic lesions from malignancies, preserving reproductive function when appropriate, and minimizing surgical complications given the cyst’s size.
- Tumor marker assessment (e.g., CA-125, AFP, hCG, inhibin) aids risk stratification.
- Imaging characteristics—septations, wall thickening, solid components—guide differential diagnosis.
- Size itself does not confirm benignancy, but mature teratomas and cystadenomas commonly present as complex cystic masses.
Surgical Management and Complications
Removal of massive ovarian cysts typically requires specialized gynecologic surgical teams. Approaches may include laparotomy, robotic, or laparoscopic techniques, with decisions based on cyst size, adherence, and patient factors. Potential intraoperative challenges include organ injury risk, hemorrhage, and the need for oophorectomy when conservation is not feasible.
Long-Term Outlook and Surveillance
After resection, most patients experience symptom relief and normal endocrine function, especially when the contralateral ovary is preserved. Pathology confirmation is essential to rule out malignancy or rare neoplastic transformation. Long-term follow-up includes clinical examination and, when indicated, imaging for recurrence or new ovarian pathology.